US3759265A - Tem pulse width controlled heartbeat stimulating apparatus monitoring sys - Google Patents

Tem pulse width controlled heartbeat stimulating apparatus monitoring sys Download PDF

Info

Publication number
US3759265A
US3759265A US00251412A US3759265DA US3759265A US 3759265 A US3759265 A US 3759265A US 00251412 A US00251412 A US 00251412A US 3759265D A US3759265D A US 3759265DA US 3759265 A US3759265 A US 3759265A
Authority
US
United States
Prior art keywords
pulse
voltage
width
power supply
heartbeat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US00251412A
Inventor
S Thaler
B Berkovits
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
American Optical Corp
Original Assignee
American Optical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Optical Corp filed Critical American Optical Corp
Application granted granted Critical
Publication of US3759265A publication Critical patent/US3759265A/en
Assigned to COOK PACEMAKER CORPORATION reassignment COOK PACEMAKER CORPORATION LICENSE (SEE DOCUMENT FOR DETAILS). EFFECTIVE 03/27/81 Assignors: ATLANTIC RICHFIELD COMPANY
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/362Heart stimulators
    • A61N1/365Heart stimulators controlled by a physiological parameter, e.g. heart potential
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/38Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
    • A61N1/39Heart defibrillators
    • A61N1/3925Monitoring; Protecting
    • A61N1/3931Protecting, e.g. back-up systems
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01RMEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R29/00Arrangements for measuring or indicating electric quantities not covered by groups G01R19/00 - G01R27/00
    • G01R29/02Measuring characteristics of individual pulses, e.g. deviation from pulse flatness, rise time or duration
    • G01R29/027Indicating that a pulse characteristic is either above or below a predetermined value or within or beyond a predetermined range of values
    • G01R29/0273Indicating that a pulse characteristic is either above or below a predetermined value or within or beyond a predetermined range of values the pulse characteristic being duration, i.e. width (indicating that frequency of pulses is above or below a certain limit)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/38Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
    • A61N1/39Heart defibrillators
    • A61N1/3906Heart defibrillators characterised by the form of the shockwave

Definitions

  • ABSTRACT Pulse-width controlled heartbeat stimulating apparatus includes an electrical power supply and a pulser for generating stimulation pulses on terminals connected to a patients heart.
  • An integral control is provided for automatically varying the width of the stimulation pulses as a function of the power supply (energy source) value to maintain the energy output above a predetermined level.
  • the present invention can be used with many types of heart stimulating devices including extra-corporeal pacers, but is particularly useful when utilized with non-accessible or implanted pacers.
  • a circuit is provided for indicating the approximate amount of remaining power supply life and for controlling energy supplied to the heart with each stimulation pulse to greater than a minimum required value regardless of energy source variation.
  • the present invention relates generally to electronic heartbeat-stimulating apparatus. More particularly, the present invention relates to a system for automatically controlling the energy in each heartbeat-stimulating pulse and to a system for indicating the remaining useful life of the battery power supply.
  • a certain quantity of energy is required to stimulate a heartbeat. This energy varies from person to person and is herein termed capture energy."
  • capture energy Initially after implantation of a particular pacer, battery voltages are maximum.
  • a sufficiently large pulse width must have been provided at the time of implantation.
  • the pulse width is preset to be large a great deal of the batterys energy is not used efficiently, since it is an excess over the required energy.
  • the pulse width set exactly at the minimum width required to provide capture energy immediately after implantation. After a period of time when battery voltages diminish or when a battery fails, pulse height will correspondingly diminish and there will be insufficient energy associated with the pulse to cause capture.
  • Applicants provide a device for maintaining the energy of each stimulation pulse approximately constant (equal to or greater than the required capture energy) for the duration of heart stimulator use.
  • the present invention relates to a system for controlling the width of pulses used for heartbeat stimulation.
  • the invention includes a device for sensing variations in the power supply. It controls the width of stimulation pulses in response to variations in the power supply in such a manner as to maintain energy of the stimulation pulses approximately constant.
  • the pulse width control includes a device for automatically varying a time constant circuit in accordance with variations of power supply voltage.
  • the present invention also relates to a system for monitoring the power supply or batteries of the heartbeat stimulating apparatus.
  • This system provides an indication of the remaining life of the batteries. This information is particularly useful in connection with an implantable pacer.
  • An eX-vivo (external) indication of battery life of an implanted heart pacer is obtained on a simple oscilloscope with the use of ordinary ECG leads.
  • the ECG leads sense the stimulation pulse and it is displayed on the oscilloscope.
  • the width of the displayed pulse provides information from which the remaining useful life (or the amount of life used up) of the battery or batteries is determined.
  • One salient feature or advantage of the present invention is its ability to allow a physician to determine useful remaining battery life without resorting to a surgical procedure in order to remove the batteries and have the batteries checked.
  • a second distinct advantage of the present invention is that it permits efficient pre-setting of the stimulation pulse width for maximum utilization of the supply batteries. This extends battery life and extends the time between implanted pacer replacement surgical operations.
  • FIG. I is a circuit diagram of a type of demand pacer that is disclosed in US. Pat. No. 3,528,428 incorporating the improvement of the present invention
  • FIG. 2 is a circuit diagram of part of a heartbeat stimulating device of the type disclosed in patent application Ser. No. 10,225 including the improvement of the present invention.
  • FIG. 3 is a graph of two superimposed stimulation pulses plotting amplitude vs. time.
  • FIG. 1 is a circuit schematic diagram of a demand pacer of the type disclosed in US. Pat. No. 3,528,428. Subject matter disclosed in that patent is incorporated herein by reference. Thus, only partial operation of this circuitry will be described below. The reader is referred to US. Pat. No. 3,528,428 for complete description of the circuitry. For purposes of simplifying the discussion, consider switch 8 to be closed thereby rendering transistor T6 non-conductive. (The present invention is operative with switch S open as well.)
  • capacitor 57 is a timing capacitor. It charges from the series arrangement of batteries 3, 5, and 7, (hereafter referred to sometimes as the energy source or as the battery) through potentiometers 35 and 37 and resistors 61 and 63. The voltage on capacitor 57 charges to a threshold voltage determined by the voltage on the base of transistor T7 established in this embodiment by batteries 3 and 5. When the voltage on capacitor 57 exceeds the voltage on the base of transistor T7 by the base-emitter voltage drop, transistor T7 is rendered conductive, which renders transistor T8 conductive. Transistor T7 and T8 conduct and capacitor 57 discharges through both transistors and only potentiometer 37 (in US. Pat. No. 3,528,428).
  • the improvement depicted in a particular illustrative embodiment comprises resistors 100, 101, 102, and 103, and transistor T100. These components are arranged in an integral control circuit to sense fluctuations in battery voltage and to automatically vary its effective circuit resistance value in accordance therewith. (In U.S. Pat. No. 3,528,428, junctions 104, 105, and 106 are a common, unnumbered junction.)
  • resistor is in parallel connection with the emitter-collector of transistor T100.
  • the collector of transistor T100 is connected to junction 104.
  • the emitter of transistor T100 is connected to one end of resistor 10], the other end being connected to junction 105.
  • the base of transistor T100 is connected to resistor I02, the other end being connected to junction 106.
  • Resistor 103 is connected between junctions and 106.
  • the charge path of capacitor 57 still includes resitors 61 and 63 since capacitor 57 is charged from batteries through that circuitry, and the discharge path of capacitor 57 still does not involve resistors 61 and 63. But now, capacitor 57 discharges not only through potentiometer 37, but also through resistor 101 and the parallel combination of resistor 100 and transistor T100. (Potentiometer 37 is still used to preset the pulse width but otherwise can be considered as series resistance in the discharge path of capacitor 57. Functionally, it can be considered to be lumped in with the resistance value of resistor 10].) A resistor can replace potentiometer 37.
  • Resistor 103 can be considered to be one resistor of a resistive voltage divider across batteries 3, 5, and 7.
  • the resistive voltage divider comprises resistors 61 and 63, potentiometer 35 and resistor 103.
  • resistor 103 acts as the biasing source of transistor T100.
  • the voltage developed across resistor 103 is due to current flow therethrough only from the series of batteries, and not from capacitor 57.
  • resistor 103 is a battery voltage sensing resistor. It can also be considered as an energy-source sensing or battery-current sensing resistor.
  • transistor T100 acts like a variable resistor automatically controlled by its base current which is proportional to voltage developed across sampling or sensing resistor 103.
  • capacitor 57 will discharge with ease in a relatively short time through this low resistance path. This is what we expect and desire when the battery potential is high or at a maximum.
  • Resistor 103 now develops smaller voltage than before and voltage applied to base-emitter terminals of transistor T100 and base current of transistor T100 are proportionately reduced.
  • the usual effect on a transistor of reducing its base current is to decrease the ability with which it can conduct current between its emitter and collector.
  • Transistor T100 thus conducts less current and acts like an increased resistance in the discharge path of capacitor 57. Accordingly, for lower battery voltages, capacitor 57 requires a greater time to discharge completely than it required in the previous example. Thus, discharge time of capacitor 57 is automatically controlled by battery voltage in this integral pulse control.
  • FIG. 2 is a partial schematic of a demand pacer of the type disclosed in patent application Ser. No. 10,225. It may functionally be the same as US. Pat. No. 3,528,428 but has at least one important difference.
  • the battery arrangement and the biasing arrangement for transistors T7 and T8 are different. Any decrease in any battery value is proportionately sensed at the base of transistor T7. Thus, the threshold at the base of T7 moves in direct proportion to the variation of supply voltage.
  • the improvement which comprises the present invention operates with the circuitry of FIG. 2 as it operated with the circuitry of FIG. 1.
  • FIG. 3 represents two pulses that are used for stimulation of a heartbeat.
  • Pulse A is generated when the battery voltage is high or at its maximum.
  • the pulse amplitude is correspondingly high or maximum, and the pulse width is low or minimum.
  • pulse B represents the heart stimulation pulse generated after a period of use.
  • the pulse amplitude is substantially reduced and the pulse width is substantially increased.
  • Shaded area a is approximately equal to shaded area b.
  • area of pulse A is approximately equal to area of pulse B. This is the situation in which the energy supplied to the heart remains approximately constant over a period of time even though the supply voltage varies.
  • Pulse area is preset with potentiometer 37 to the capture energy required by the particular patient being stimulated.
  • the pulse width does not increase as amplitude decreases. There would be insufficient energy associated with future pulses to cause capture (to stimulate a heartbeat). Therefore, to ensure capture at a future time, an excessive amount of energy would initially have to be used, and thus some would be wasted.
  • the width of pulse A would have to be made at least as large as the width of pulse B to ensure capture at the amplitude of pulse B when not using the present invention.
  • the width of the heart stimulation pulse is inversely related to the amplitude of the battery supply. This relationship could be of the form where the product of battery voltage and pulse width is a constant. But, other relationships can work also.
  • electrocardiogram leads operatively connected to an oscilloscope to externally sense and display the stimulation pulse width, one can monitor the batteries and provide an indication of remaining battery life.
  • the pulse width indicates battery usage. Quantitative measurements can be made.
  • the present invention includes an implantable pacerbattery external monitoring-system.
  • any point in the circuitry which varies as a function of the energy supply can be used to control at least one transistor switch which in turn can control stimulation pulse width in a discrete fashion.
  • the present embodiments are to be considered in all respects as illustrative and not restrictive, the scope of the invention being indicated by the appended claims rather than by the foregoing description, and all changes which come within the meaning and range of equivalency of the claims are therefore intended to be embraced therein.
  • a monitoring system comprising heartbeat stimulating apparatus for providing electrical pulses for stimulating the heartbeat of a patient, a power supply for supplying voltage to said apparatus, means for sensing decrease of said voltage, and pulse-width control means responsive to the operation of said sensing means for controllably varying the width of each of said electrical pulses as a function of said voltage decrease and thus providing an indication of said voltage remaining in said supply.

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • Electrotherapy Devices (AREA)

Abstract

Pulse-width controlled heartbeat stimulating apparatus. The apparatus includes an electrical power supply and a pulser for generating stimulation pulses on terminals connected to a patient''s heart. An integral control is provided for automatically varying the width of the stimulation pulses as a function of the power supply (energy source) value to maintain the energy output above a predetermined level. The present invention can be used with many types of heart stimulating devices including extra-corporeal pacers, but is particularly useful when utilized with non-accessible or implanted pacers. In an illustrative embodiment, a circuit is provided for indicating the approximate amount of remaining power supply life and for controlling energy supplied to the heart with each stimulation pulse to greater than a minimum required value regardless of energy source variation.

Description

United States Patent 1 Thaler et al.
[ 1 Sept. 18, 1973 1 1 PULSE-WIDTH CONTROLLED HEARTBEAT STIMULATING APPARATUS MONITORING SYSTEM [75] Inventors: Sherwood S. Thaler, Lexington;
Barough V. Berkovits, Newton Highlands, both of Mass.
[73] Assignee: American Optical Corporation,
Southbridge, Mass.
[22] Filed: May 8, 1972 [21] Appl. No.: 251,412
[52] US. Cl 128/419 P, 128/205 R [51] Int. Cl A6ln 1/36 [58] Field of Search 128/205 P, 2.05 R,
128/205 T, 2.06 F, 2.06 R, 419 P, 421, 422
[56] References Cited UNITED STATES PATENTS Millen 128/419 P X Keller, Jr 128/419 P Primary Examiner-William E. Kamm Attorney-William C. Nealon et a1.
[57] ABSTRACT Pulse-width controlled heartbeat stimulating apparatus. The apparatus includes an electrical power supply and a pulser for generating stimulation pulses on terminals connected to a patients heart. An integral control is provided for automatically varying the width of the stimulation pulses as a function of the power supply (energy source) value to maintain the energy output above a predetermined level. The present invention can be used with many types of heart stimulating devices including extra-corporeal pacers, but is particularly useful when utilized with non-accessible or implanted pacers. ln an illustrative embodiment, a circuit is provided for indicating the approximate amount of remaining power supply life and for controlling energy supplied to the heart with each stimulation pulse to greater than a minimum required value regardless of energy source variation.
2 Claims, 3 Drawing Figures PAIENIEDSEP 3.759.265
SHEET 1 BF 2 FIG.|
PAIEmEusrmm 3 759 26s SHEEI 2 0F 2 time FIG. 3
as i r? FIG.2
PULSE-WIDTH CONTROLLED IIEARTBEAT STIMULATING APPARATUS MONITORING Y SYSTEM CROSS-REFERENCE TO RELATED APPLICATIONS The present application is a division of co-pending US. Pat. application Ser. No. 163,619 filed July 19, 1971 which in turn is a continuation-in-part of U.S. Pat. application Ser. No. 16,478 entitled Electrocardiographic Monitor System filed Mar. 4, 1970 which has matured into US. Pat. No. 3,674,015 and which is a division of patent application Ser. No. 727,129 entitled Demand Pacer which was filed on Apr. 11, 1968 and which issued as US. Pat. No. 3,528,428. Background information disclosed in US. Pat. No. 3,528,428 is incorporated herein by reference. The present application is related to the following co-pending applications: US. Pat. application Ser. No. 10,225 entitled Pacemaker filed Feb. 10, 1970 and which issued as US. Pat. No. 3,635,224; US. Pat. Application Ser. No. 810,519 entitled Atrial and Ventricular Demand Pacer filed Mar. 26, 1969; and which issued as US. Pat. No. 3,595,242 and US. Pat. application Ser. No. 884,825 entitled Bifocal Demand Pacemaker filed Dec. l5, 1969 and which issued as US. Pat. No. 3,661,158. All of the above copending patent applications are tiled in the name of Barouh V. Berkovits, who is a joint inventor in the present patent application, and are assigned to the same assignee as that of the present patent application. Subject matter of these related applications is incorporated herein by reference.
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates generally to electronic heartbeat-stimulating apparatus. More particularly, the present invention relates to a system for automatically controlling the energy in each heartbeat-stimulating pulse and to a system for indicating the remaining useful life of the battery power supply.
2. Description of Prior Art In the burgeoning field of medical-electronics, electronic pacer devices for providing stimulation to a patients heart to induce a heartbeat have been developed over the past years or so. Stimulating devices of the demand type, wherein stimulation is provided only in the absence of natural heartbeats have been developed and such devices are disclosed in certain of the copending patent applications herein referenced. And more recently, devices of the type which will stimulate the atrium and the ventricle separately have been developed and are disclosed in certain of the copending patent applications herein referenced. The present invention is yet another improvement in the growing family of improvements to heart-stimulating devices.
In the implantable variety of pacers, batteries in a series string are commonly employed as a power supply. Batteries, of course, run down and fail individually after periods of time. One of the problems with most heart stimulating devices to date, and particularly with the implantable variety, results from battery deterioration combined with fixed pulse-width of the heartbeat stimulation pulse. A problem is that energy of the stimulation pulse (wherein the energy is related to but not equal to battery voltage decreases. This will eventually cause malfunction of the pacer.
A certain quantity of energy is required to stimulate a heartbeat. This energy varies from person to person and is herein termed capture energy." Initially after implantation of a particular pacer, battery voltages are maximum. To provide capture energy initially after implantation, one requires a relatively narrow pulse. The pulse area is sufficiently large due to relatively large pulse height. By comparison, to provide capture energy at a later point in time, (for example, one year after implantation when battery voltages have diminished) a sufficiently large pulse width must have been provided at the time of implantation.
Thus, on the one hand, if the pulse width is preset to be large a great deal of the batterys energy is not used efficiently, since it is an excess over the required energy. On the other hand, consider the pulse width set exactly at the minimum width required to provide capture energy immediately after implantation. After a period of time when battery voltages diminish or when a battery fails, pulse height will correspondingly diminish and there will be insufficient energy associated with the pulse to cause capture.
This capture energy and efficiency problem is solved by the present invention. Applicants provide a device for maintaining the energy of each stimulation pulse approximately constant (equal to or greater than the required capture energy) for the duration of heart stimulator use.
Another problem associated with inaccessible pacers is the lack of information relating to battery usage and- /or to remaining battery life. The inaccessibility of implanted pacers makes direct measurement of the batteries impractical. Patients and physicians were not certain as to when the batteries would deteriorate to the extent that the pacer would malfunction. This uncertainty created unnecessary anguish for the patient. The present invention provides a solution to this problem with an external monitoring/indicating system for indicating the remaining useful life of the implanted pacer batteries.
SUMMARY OF THE INVENTION The present invention relates to a system for controlling the width of pulses used for heartbeat stimulation. The invention includes a device for sensing variations in the power supply. It controls the width of stimulation pulses in response to variations in the power supply in such a manner as to maintain energy of the stimulation pulses approximately constant. The pulse width control includes a device for automatically varying a time constant circuit in accordance with variations of power supply voltage.
The present invention also relates to a system for monitoring the power supply or batteries of the heartbeat stimulating apparatus. This system provides an indication of the remaining life of the batteries. This information is particularly useful in connection with an implantable pacer. An eX-vivo (external) indication of battery life of an implanted heart pacer is obtained on a simple oscilloscope with the use of ordinary ECG leads. The ECG leads sense the stimulation pulse and it is displayed on the oscilloscope. The width of the displayed pulse provides information from which the remaining useful life (or the amount of life used up) of the battery or batteries is determined.
There are several advantages of the present invention. One salient feature or advantage of the present invention is its ability to allow a physician to determine useful remaining battery life without resorting to a surgical procedure in order to remove the batteries and have the batteries checked.
A second distinct advantage of the present invention is that it permits efficient pre-setting of the stimulation pulse width for maximum utilization of the supply batteries. This extends battery life and extends the time between implanted pacer replacement surgical operations.
It is thus an object of the present invention to provide a heartbeat-stimulating device which has an approximately constant stimulation-pulse energy.
It is yet another object of the present invention to provide a monitoring system for indicating remaining useful life of the pacer power source.
Other objects and advantages of the present invention will become apparent to one having reasonable skill in the art after referring to the detailed descriptions of the appended drawings in which:
BRIEF DESCRIPTION OF THE DRAWINGS FIG. I is a circuit diagram of a type of demand pacer that is disclosed in US. Pat. No. 3,528,428 incorporating the improvement of the present invention;
FIG. 2 is a circuit diagram of part ofa heartbeat stimulating device of the type disclosed in patent application Ser. No. 10,225 including the improvement of the present invention; and,
FIG. 3 is a graph of two superimposed stimulation pulses plotting amplitude vs. time.
DESCRIPTION OF THE PREFERRED EMBODIMENT FIG. 1 is a circuit schematic diagram of a demand pacer of the type disclosed in US. Pat. No. 3,528,428. Subject matter disclosed in that patent is incorporated herein by reference. Thus, only partial operation of this circuitry will be described below. The reader is referred to US. Pat. No. 3,528,428 for complete description of the circuitry. For purposes of simplifying the discussion, consider switch 8 to be closed thereby rendering transistor T6 non-conductive. (The present invention is operative with switch S open as well.)
In US. Pat. No. 3,528,428, capacitor 57 is a timing capacitor. It charges from the series arrangement of batteries 3, 5, and 7, (hereafter referred to sometimes as the energy source or as the battery) through potentiometers 35 and 37 and resistors 61 and 63. The voltage on capacitor 57 charges to a threshold voltage determined by the voltage on the base of transistor T7 established in this embodiment by batteries 3 and 5. When the voltage on capacitor 57 exceeds the voltage on the base of transistor T7 by the base-emitter voltage drop, transistor T7 is rendered conductive, which renders transistor T8 conductive. Transistor T7 and T8 conduct and capacitor 57 discharges through both transistors and only potentiometer 37 (in US. Pat. No. 3,528,428).
The improvement depicted in a particular illustrative embodiment comprises resistors 100, 101, 102, and 103, and transistor T100. These components are arranged in an integral control circuit to sense fluctuations in battery voltage and to automatically vary its effective circuit resistance value in accordance therewith. (In U.S. Pat. No. 3,528,428, junctions 104, 105, and 106 are a common, unnumbered junction.)
In the control circuit, resistor is in parallel connection with the emitter-collector of transistor T100. The collector of transistor T100 is connected to junction 104. The emitter of transistor T100 is connected to one end of resistor 10], the other end being connected to junction 105. The base of transistor T100 is connected to resistor I02, the other end being connected to junction 106. Resistor 103 is connected between junctions and 106.
In the present invention the charge path of capacitor 57 still includes resitors 61 and 63 since capacitor 57 is charged from batteries through that circuitry, and the discharge path of capacitor 57 still does not involve resistors 61 and 63. But now, capacitor 57 discharges not only through potentiometer 37, but also through resistor 101 and the parallel combination of resistor 100 and transistor T100. (Potentiometer 37 is still used to preset the pulse width but otherwise can be considered as series resistance in the discharge path of capacitor 57. Functionally, it can be considered to be lumped in with the resistance value of resistor 10].) A resistor can replace potentiometer 37.
Resistor 103 can be considered to be one resistor of a resistive voltage divider across batteries 3, 5, and 7. The resistive voltage divider comprises resistors 61 and 63, potentiometer 35 and resistor 103.
In operation, the voltage developed across resistor 103 acts as the biasing source of transistor T100. The higher the voltage developed across resistor 103, the greater the voltage applied to the circuitry to its left. The voltage developed across resistor 103 is due to current flow therethrough only from the series of batteries, and not from capacitor 57. Thus, resistor 103 is a battery voltage sensing resistor. It can also be considered as an energy-source sensing or battery-current sensing resistor.
The voltage developed across resistor 103 causes a base current to flow from emitter to base in transistor T100 (in the direction of the emitter arrow). The greater the base current, the more transistor T100 turns on and the more readily it conducts capacitor 57 discharge current from its emitter to its collector. Thus, transistor T100 acts like a variable resistor automatically controlled by its base current which is proportional to voltage developed across sampling or sensing resistor 103.
If the pacer were recently implanted, the battery voltage is high or at a peak; transistor T100 is strongly turned on, and its effective resistance to flow of emitter-collector current is relatively low. Thus, capacitor 57 will discharge with ease in a relatively short time through this low resistance path. This is what we expect and desire when the battery potential is high or at a maximum.
By comparison, consider a period of time after implantation (i.e. perhaps a year or so) during which the batteries have individually failed or diminished by vir tue of their use. For this situation, after capacitor 57 charges sufficiently to overcome the threshold established on the base of transistor T7, transistors T7 and T8 conduct current as usual. However, when the transistors conduct (and provide a discharge path for capacitor 57 through them and through resistors 101 and 100, and transistor T100), a lower battery voltage is impressed across the resistive voltage divider than described in the previous paragraph.
Resistor 103 now develops smaller voltage than before and voltage applied to base-emitter terminals of transistor T100 and base current of transistor T100 are proportionately reduced. The usual effect on a transistor of reducing its base current is to decrease the ability with which it can conduct current between its emitter and collector. Transistor T100 thus conducts less current and acts like an increased resistance in the discharge path of capacitor 57. Accordingly, for lower battery voltages, capacitor 57 requires a greater time to discharge completely than it required in the previous example. Thus, discharge time of capacitor 57 is automatically controlled by battery voltage in this integral pulse control.
FIG. 2 is a partial schematic of a demand pacer of the type disclosed in patent application Ser. No. 10,225. It may functionally be the same as US. Pat. No. 3,528,428 but has at least one important difference. The battery arrangement and the biasing arrangement for transistors T7 and T8 are different. Any decrease in any battery value is proportionately sensed at the base of transistor T7. Thus, the threshold at the base of T7 moves in direct proportion to the variation of supply voltage. The improvement which comprises the present invention operates with the circuitry of FIG. 2 as it operated with the circuitry of FIG. 1.
The effect of the discharge time control circuit may best be illustrated by reference to FIG. 3. FIG. 3 represents two pulses that are used for stimulation of a heartbeat. Pulse A is generated when the battery voltage is high or at its maximum. The pulse amplitude is correspondingly high or maximum, and the pulse width is low or minimum. Conversely, pulse B represents the heart stimulation pulse generated after a period of use. The pulse amplitude is substantially reduced and the pulse width is substantially increased. Shaded area a is approximately equal to shaded area b. Thus, area of pulse A is approximately equal to area of pulse B. This is the situation in which the energy supplied to the heart remains approximately constant over a period of time even though the supply voltage varies. Pulse area is preset with potentiometer 37 to the capture energy required by the particular patient being stimulated.
But, if area of pulse A is initially preset to the minimum energy necessary to provide capture, and if the present invention is not used, the pulse width does not increase as amplitude decreases. There would be insufficient energy associated with future pulses to cause capture (to stimulate a heartbeat). Therefore, to ensure capture at a future time, an excessive amount of energy would initially have to be used, and thus some would be wasted. For example, the width of pulse A would have to be made at least as large as the width of pulse B to ensure capture at the amplitude of pulse B when not using the present invention.
According to the present invention, the width of the heart stimulation pulse is inversely related to the amplitude of the battery supply. This relationship could be of the form where the product of battery voltage and pulse width is a constant. But, other relationships can work also. Thus, one can monitor the failure of an individual battery or deterioration of the entire battery supply voltage by monitoring the heart stimulation pulse. By using electrocardiogram leads operatively connected to an oscilloscope to externally sense and display the stimulation pulse width, one can monitor the batteries and provide an indication of remaining battery life. The pulse width indicates battery usage. Quantitative measurements can be made. Thus, the present invention includes an implantable pacerbattery external monitoring-system.
The invention may be embodied in other specific forms without departing from the spirit or essential characteristics thereof. For example, any point in the circuitry which varies as a function of the energy supply can be used to control at least one transistor switch which in turn can control stimulation pulse width in a discrete fashion. Thus, the present embodiments are to be considered in all respects as illustrative and not restrictive, the scope of the invention being indicated by the appended claims rather than by the foregoing description, and all changes which come within the meaning and range of equivalency of the claims are therefore intended to be embraced therein.
We claim:
1. A monitoring system comprising heartbeat stimulating apparatus for providing electrical pulses for stimulating the heartbeat of a patient, a power supply for supplying voltage to said apparatus, means for sensing decrease of said voltage, and pulse-width control means responsive to the operation of said sensing means for controllably varying the width of each of said electrical pulses as a function of said voltage decrease and thus providing an indication of said voltage remaining in said supply.
2. A monitoring system as recited in claim 1 and wherein said pulse-width control means includes means for increasing the width of said each of said electrical pulses to compensate for said voltage decrease of said power supply, and wherein said monitoring system is capable of being implanted within the body of said patient.

Claims (2)

1. A monitoring system comprising heartbeat stimulating apparatus for providing electrical puLses for stimulating the heartbeat of a patient, a power supply for supplying voltage to said apparatus, means for sensing decrease of said voltage, and pulse-width control means responsive to the operation of said sensing means for controllably varying the width of each of said electrical pulses as a function of said voltage decrease and thus providing an indication of said voltage remaining in said supply.
2. A monitoring system as recited in claim 1 and wherein said pulse-width control means includes means for increasing the width of said each of said electrical pulses to compensate for said voltage decrease of said power supply, and wherein said monitoring system is capable of being implanted within the body of said patient.
US00251412A 1968-04-11 1972-05-08 Tem pulse width controlled heartbeat stimulating apparatus monitoring sys Expired - Lifetime US3759265A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US72712968A 1968-04-11 1968-04-11
US1647870A 1970-03-04 1970-03-04
US25141272A 1972-05-08 1972-05-08

Publications (1)

Publication Number Publication Date
US3759265A true US3759265A (en) 1973-09-18

Family

ID=27360571

Family Applications (1)

Application Number Title Priority Date Filing Date
US00251412A Expired - Lifetime US3759265A (en) 1968-04-11 1972-05-08 Tem pulse width controlled heartbeat stimulating apparatus monitoring sys

Country Status (1)

Country Link
US (1) US3759265A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0006207A1 (en) * 1978-06-12 1980-01-09 Enz-Rüdiger Dr. Von Leitner Implantable cardiac pacemaker
US4276883A (en) * 1978-11-06 1981-07-07 Medtronic, Inc. Battery monitor for digital cardiac pacemaker
WO1989000061A1 (en) * 1987-06-30 1989-01-12 Micromedical Industries Pty Limited Combined pacemaker parameter and vital sign monitor
US4817605A (en) * 1984-10-19 1989-04-04 Siemens-Pacesetter, Inc. Pacemaker system and method for measuring and monitoring cardiac activity and for determining and maintaining capture
WO1991016102A1 (en) * 1990-04-24 1991-10-31 Siemens Aktiengesellschaft Tissue stimulating device
US5800461A (en) * 1992-11-19 1998-09-01 Cardiac Pacemakers, Inc. Constant charge time of defibrillation capacitor

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0006207A1 (en) * 1978-06-12 1980-01-09 Enz-Rüdiger Dr. Von Leitner Implantable cardiac pacemaker
US4276883A (en) * 1978-11-06 1981-07-07 Medtronic, Inc. Battery monitor for digital cardiac pacemaker
US4817605A (en) * 1984-10-19 1989-04-04 Siemens-Pacesetter, Inc. Pacemaker system and method for measuring and monitoring cardiac activity and for determining and maintaining capture
WO1989000061A1 (en) * 1987-06-30 1989-01-12 Micromedical Industries Pty Limited Combined pacemaker parameter and vital sign monitor
WO1991016102A1 (en) * 1990-04-24 1991-10-31 Siemens Aktiengesellschaft Tissue stimulating device
US5391191A (en) * 1990-04-24 1995-02-21 Siemens Aktiengesellschaft Device for tissue stimulation
US5800461A (en) * 1992-11-19 1998-09-01 Cardiac Pacemakers, Inc. Constant charge time of defibrillation capacitor

Similar Documents

Publication Publication Date Title
US7761161B2 (en) Cardiac rhythm management system with user interface for threshold test
US4399818A (en) Direct-coupled output stage for rapid-signal biological stimulator
US4917093A (en) Biological tissue stimulator with adjustable high voltage power supply dependent upon load impedance
US5431682A (en) Implantable heart defibrillator
US3713449A (en) Cardiac pacer with externally controllable variable width output pulse
US4406286A (en) Fast recharge output circuit
US3057356A (en) Medical cardiac pacemaker
US6760624B2 (en) Method and apparatus for measuring lead impedance in an implantable cardiac rhythm management device
CA1091301A (en) P-wave control, r-wave inhibited ventricular stimulation device
US6185461B1 (en) System and method for verification of recommended replacement time indication in an implantable cardiac stimulation device
DE3175940D1 (en) Programmable cardiac pacemaker
US3618615A (en) Self checking cardiac pacemaker
JP2809511B2 (en) Cardiac pacemaker with programmable output pulse amplitude
US3698398A (en) Rate-scanning pacer for treatment of tachycardia
US3871383A (en) Power supply
US3693626A (en) Demand pacer with heart rate memory
US6823215B2 (en) Implantable heart stimulator with microinstability testing for electrode contact with tissue
Luceri et al. Threshold behavior of electrodes in long-term ventricular pacing
US3774619A (en) Source testing cardiac pacer with source-independent rate circuitry and disabling means therefor
US3901247A (en) End of life increased pulse width and rate change apparatus
US3746005A (en) Constant energy heartbeat stimulating apparatus with pulse width control
US3759265A (en) Tem pulse width controlled heartbeat stimulating apparatus monitoring sys
US3746006A (en) Controlled energy output pacer
US3837348A (en) Externally-controlled implantable cardiac-pacer capture margin testing apparatus and method
IL37845A (en) Cardiac pacer for providing artificial demand cardiac electrical impulses

Legal Events

Date Code Title Description
AS Assignment

Owner name: COOK PACEMAKER CORPORATION, INDIANA

Free format text: LICENSE;ASSIGNOR:ATLANTIC RICHFIELD COMPANY;REEL/FRAME:003852/0285

Effective date: 19810327

Owner name: COOK PACEMAKER CORPORATION, P.O. BOX 99, BLOOMINGT

Free format text: LICENSE;ASSIGNOR:ATLANTIC RICHFIELD COMPANY;REEL/FRAME:003852/0285

Effective date: 19810327